0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

• Status: Enrolling by invitation
• Trial end date: 2020-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However, it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of non-ventilator hospital-acquired pneumonia among hospitalized patients.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: National Cheng-Kung University Hospital
• Treatments: Chlorhexidine; Listerine

Criteria

Inclusion Criteria:

• Hospitalized patients > 20 years old without ventilator

Exclusion Criteria:

• known hypersensitivity to or intolerance of Chlorhexidine or Listerine